Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome.
Hoenig M,Lagresle-Peyrou C,Pannicke U,Notarangelo L,Porta F,Gennery A,Slatter M,Cowan M,Stepensky P,Al-Mousa H,Al-Zahrani D,Pai S,Al Herz W,Gaspar H,Veys P,Oshima K,Imai K,Yabe H,Noroski L,Wulffraat N,Sykora K,Soler-Palacin P,Muramatsu H,Al Hilali M,Moshous D,Debatin K,Schuetz C,Jacobsen E,Schulz A,Schwarz K,Fischer A,Friedrich W,Cavazzana M
Source :
Blood
2017 Mar 22
Pmid / DOI:
28331055
Abstract
Reticular dysgenesis (RD) is a rare congenital disorder defined clinically by the combination of severe combined immunodeficiency (SCID), agranulocytosis, and sensorineural deafness. Mutations in the gene encoding adenylate kinase 2 were identified to cause the disorder. Hematopoietic stem cell transplantation (HSCT) is the only option to cure this otherwise fatal disease. Retrospective data on clinical presentation, genetics, and outcome of HSCT were collected from centers in Europe, Asia, and North America for a total of 32 patients born between 1982 and 2011. Age at presentation was